Prosecution Insights
Last updated: August 14, 2026
Application No. 17/144,991

SUBSTRATE WITH CHANNELS FOR CONTROLLED FLUID FLOW IN BIOLOGICAL ASSAY SAMPLING

Non-Final OA §103
Filed
Jan 08, 2021
Priority
Jan 10, 2020 — provisional 62/959,748
Examiner
WHITE, DENNIS MICHAEL
Art Unit
1758
Tech Center
1700 — Chemical & Materials Engineering
Assignee
Quidel Corporation
OA Round
7 (Non-Final)
58%
Grant Probability
Moderate
7-8
OA Rounds
0m
Est. Remaining
99%
With Interview

Examiner Intelligence

Grants 58% of resolved cases
58%
Career Allowance Rate
480 granted / 831 resolved
-7.2% vs TC avg
Strong +49% interview lift
Without
With
+48.7%
Interview Lift
resolved cases with interview
Typical timeline
3y 0m
Avg Prosecution
23 currently pending
Career history
849
Total Applications
across all art units

Statute-Specific Performance

§101
1.8%
-38.2% vs TC avg
§103
45.2%
+5.2% vs TC avg
§102
28.0%
-12.0% vs TC avg
§112
14.4%
-25.6% vs TC avg
Black line = Tech Center average estimate • Based on career data from 831 resolved cases

Office Action

§103
DETAILED ACTION Notice of Pre-AIA or AIA Status The present application, filed on or after March 16, 2013, is being examined under the first inventor to file provisions of the AIA . Continued Examination Under 37 CFR 1.114 A request for continued examination under 37 CFR 1.114, including the fee set forth in 37 CFR 1.17(e), was filed in this application after final rejection. Since this application is eligible for continued examination under 37 CFR 1.114, and the fee set forth in 37 CFR 1.17(e) has been timely paid, the finality of the previous Office action has been withdrawn pursuant to 37 CFR 1.114. Applicant's submission filed on 12/8/2025 has been entered. Response to Arguments Applicant argues that "nowhere in Chang's disclosure is there any mention or even suggestion of fluid flow channels containing angular entrance constriction regions between a common single sample zone and a channel constriction zone as presently claimed. In particular, Applicant submits that Chang fails to teach such an angular entrance constriction region having a projecting portion that expands into the fluid flow channel at an angle that is between about 30- 90°. Further, Chang does not teach the specific geometric shapes of the projecting portion set forth in independent claim 1 i.e., a half-rhombus, half-rectangle, half-square, quarter-rectangle, half-parallelogram, quarter-parallelogram, or half-kite." This argument is not convincing as the rejection is now a 103 rejection where the fluid control features angles and shapes are result effective to control the fluid flow. Additionally, applicant argues, "the Office asserts that Chang discloses a plurality of discrete fluid flow channels where n is between 2-20 and where each fluid flow channel is identified by an integer between 1 and n, wherein fluid flow channel 1 and fluid flow channel n each comprise an outer channel wall with a width w, and a barrier extension region positioned at the channel entrance region with a width of between about w, and about 10w. As alleged support for the anticipation rejection, the Office points to Chang's Fig. 1L and asserts that this drawing depicts a barrier extension region having an outer wall of outer flow channels with a width equal to the width of the outer channel walls." The argument was convincing, but is now moot in view of the new 103 obviousness rejection. Claim Rejections - 35 USC § 103 The text of those sections of Title 35, U.S. Code not included in this action can be found in a prior Office action. Claim(s) 1, 3-8, 12-13, 20-25, 28, 30-31, 37 is/are rejected under 35 U.S.C. 103 as being unpatentable over Chang et al (US 2018/0229232A1). Regarding claims 1, 20, Chang et al teach a device, comprising: a single, unitary substrate comprising a plurality of discrete fluid flow channels (Para. 0021: single integral substrate and plurality of discrete flow paths), a single sample zone on the substrate that is common to each fluid flow channel such that each fluid flow channel is in direct fluid communication with the sample zone at a channel entrance region of each fluid flow channel (Para. 0085: single sample receiving zone 20); each fluid flow channel having a length and a width (Fig 29), each fluid flow channel comprising a capture zone downstream from the channel entrance region (Fig. 29 capture zone downstream of the channel entrance) and a channel constriction zone positioned between the channel entrance region and the capture zone (Para. 0085, Fig. 29: fluid flow feature 28 to narrow is positioned between the channel entrance and the capture zone 30), the channel constriction zone having a width and a length, the channel constriction zone width corresponding to a value in the range determined by (i) a minimum value that is equal to or greater than a diameter of a particulate reagent deposited on or to be deposited on the substrate wherein the diameter of the particulate reagent is between about 0.05-10 microns (0.00005-0.1 mm) ii) a maximum value that is less than about 0.825 mm. (Para. 0161-0162 funnel widths of 0.5 and 0.7mm falls within the claimed range). Chang et al teach the plurality of discrete fluid flow channels comprises n fluid flow channels, where n is between 2-20. (Fig 29: 2 fluid flow channels) Chang et al teach each fluid flow channel n is identified by an integer between 1 and n (Fig. 1L (see annotated below): channels 1 through 4), and wherein fluid flow channel 1 (Fig. 1L (see annotated below) Channel 1) and fluid flow channel n (Fig. 1L (see annotated below)channel 4) each comprise an outer channel wall. Chang shows the outer channel wall and continuing to the barrier extension region having a width consistent throughout in Fig. 1L below (Fig. 1L (see annotated below): barrier extension region extends at a right angle from the outer channel wall and has a width equal to the channel wall width; Para. 0123: the wall in the sample receiving zone is the same as the barrier extension region that is perpendicular to the walls in between the channels as shown in the Fig. 1L). Chang is silent to the description of the Fig. 1L having a specific width and the Figure being drawn to scale for widths of the walls. In re Boesch (205 USPQ 215) teaches the optimization of a result effective variable is ordinarily within the skill of the art. A result effective variable is one that has well known and predictable results. The choice of a width of the wall is a result effective variable that gives the well known and expected results of providing structural support for the internal components and channels. In the absence of a showing of unexpected results, the Office maintains the width of the wall having the same width would have been within the skill of the art as optimization of a results effective variable and would provide ease of manufacturing to provide an equal width throughout the device. PNG media_image1.png 617 314 media_image1.png Greyscale Chang teach an angular entrance constriction region in each fluid flow channel positioned between the common single sample zone and the channel constriction zone, wherein the entrance constriction region comprises a projecting portion that expands into the fluid flow channel at an angle in the embodiment in both Fig. 29 and Fig. 31. The angular entrance constriction regions in these embodiments are not defined in the reference, but appear to be about 45 degrees in Fig. 29 and in Fig. 31 more acute than the square shape due to the diamond shape. The fluid control feature is described as "diamond-shaped" (Para. 0062). Chang teach diamond shaped angles appear to fall within the 30-90 degree in Fig. 29 and 31 and the "diamond shape" in Fig. 29 and 31 are sufficiently broad to read on a geometric shape of a half-rhombus or a half-parallelogram as both shapes can be rhombus and parallelograms after having been halved in a parallel cut to the sides. Chang further teaches the geometric shape and angle controls the rate of fluid flow (Para. 0085: geometric shape to control the fluid flow, 0117: angled walls to enhance the pinch point created by the fluid control feature). In re Boesch (205 USPQ 215) teaches the optimization of a result effective variable is ordinarily within the skill of the art. A result effective variable is one that has well known and predictable results. The choice of an angle between about 30-90° and a geometric shape of a half-rhombus, half-rectangle, half-square, quarter-rectangle, half- parallelogram, quarter-parallelogram, or half-kite is a result effective variable that gives the well known and expected results of providing a desired rate of fluid flow. In the absence of a showing of unexpected results, the Office maintains the choice of the embodiments in Fig. 29 and 31 to use with the device at angles between about 30-90°, wherein the projecting portion has a geometric shape of a half-rhombus, half-rectangle, half-square, quarter-rectangle, half- parallelogram, quarter-parallelogram, or half-kite (read on by the diamond shape in Fig. 29 and 31) would have been within the skill of the art as optimization of a results effective variable. Regarding claims 3 and 37, Chang et al teach a device, comprising: a single, unitary substrate comprising a plurality of discrete fluid flow channels (Para. 0021: single integral substrate and plurality of discrete flow paths), a single sample zone on the substrate that is common to each fluid flow channel such that each fluid flow channel is in direct fluid communication with the sample zone at a channel entrance region of each fluid flow channel (Para. 0085: single sample receiving zone 20); each fluid flow channel having a length and a width (Fig 29), each fluid flow channel comprising a capture zone downstream from the channel entrance region (Fig. 29 capture zone downstream of the channel entrance) and a channel constriction zone positioned between the channel entrance region and the capture zone (Para. 0085, Fig. 29: fluid flow feature 28 to narrow is positioned between the channel entrance and the capture zone 30), the channel constriction zone having a width and a length, the channel constriction zone width corresponding to a value in the range determined by (i) a minimum value that is equal to or greater than a diameter of a particulate reagent deposited on or to be deposited on the substrate wherein the diameter of the particulate reagent is between about 0.05-10 microns (0.00005-0.1 mm) ii) a maximum value that is less than about 0.825 mm. (Para. 0161-0162 funnel widths of 0.5 and 0.7mm falls within the claimed range). Chang et al teach each fluid flow channel n is identified by an integer between 1 and n (Fig. 1L (see annotated below): channels 1 through 4), and wherein fluid flow channel 1 (Fig. 1L (see annotated below) Channel 1) and fluid flow channel n (Fig. 1L (see annotated below)channel 4) each comprise an outer channel wall with a width w, and a barrier extension region positioned at the channel entrance region with a width of between about w, and about 10w (Fig. 1L (see annotated below): barrier extension region extends at a right angle from the outer channel wall and has a width equal to the channel wall width). PNG media_image1.png 617 314 media_image1.png Greyscale Chang et al teach an embodiment where the channel fluid control feature 18 length to the length of the fluid flow channel ratio can be 0.1 to 0.5 (Para. 0080: reads on a ratio range of minimum value 10% to maximum value of 50%). Chang further teach the capture pathlength affect the completion time (Par. 0064-0065, 0163; Fig. 31-32). It is well known the lengths of the channel affects the flow completion time (Fig. 32). Chang is silent to the embodiment of the Fig. 29 of the length of the fluid constriction zone is (i) a minimum value that is equal to or greater than about 8% of the fluid flow channel length, and (ii) a maximum value that is equal to or less than about 75% of the fluid flow channel length (claim 3: (i) a minimum value that is equal to or greater than about 10% of the fluid flow channel length, and (ii) a maximum value that is equal to or less than about 65% of the fluid flow channel length). It is desirable to provide a length of the channel constriction zone to provide the adequate time for the desired reaction upstream of the constriction zone. In re Boesch (205 USPQ 215) teaches the optimization of a result effective variable is ordinarily within the skill of the art. A result effective variable is one that has well known and predictable results. The choice of a minimum and maximum value for the length of the channel constriction zone is a result effective variable that gives the well known and expected results of providing control over the fluid flow upstream of the constriction zone and providing the above advantage of controlling the time for the desired reaction. In the absence of a showing of unexpected results, the Office maintains the choice of a fluid flow channel length and length of the channel constriction such that (i) a minimum value that is equal to or greater than about 8% of the fluid flow channel length, and (ii) a maximum value that is equal to or less than about 75% of the fluid flow channel length (claim 3: (i) a minimum value that is equal to or greater than about 10% of the fluid flow channel length, and (ii) a maximum value that is equal to or less than about 65% of the fluid flow channel length) (taught by the embodiment of the ratio of the lengths of 10% to 50% in Para. 0080) would have been within the skill of the art as optimization of a results effective variable. Regarding claim 4, Chang et al teach the channel constriction zone width is variable along the channel constriction zone length. (Fig. 29: constriction zone width tapers that reads on variable width) Regarding claim 5, Chang et al teach the channel constriction zone includes a taper region at an entrance region into the channel constriction zone or at an exit region of the channel constriction zone.(Fig. 29: constriction zone width tapers at both entrance and exit region) Regarding claim 6, Chang et al teach the taper region extends from the fluid flow channel width to the channel constriction zone width.(Fig. 29: constriction zone width tapers from the channel to the constriction zone width) Regarding claim 7, Chang et al teach the channel constriction zone is non-angular along its length. (Para. 0085: fluid control feature is non-angular shape) Regarding claim 8, Chang et al teach the particulate reagent is an optically detectable solid particle. (Para. 0155: europium particle fluorescence) Regarding claim 12, Chang et al teach the entrance constriction region is positioned at the channel entrance region. (Fig. 29: constriction zone at sample receiving zone) Regarding claim 13, Chang et al teach the entrance constriction region has a width and a length, wherein the entrance constriction region width is essentially the same as the channel constriction zone. (Fig. 29, Para. 0161: constriction zone at sample receiving zone same width as the second fluid control at the conjugate zone) Regarding claim 21, Chang et al teach the substrate is nitrocellulose. (Para. 0075) Regarding claims 22-24, Chang et al teach each capture zone comprises a different capture reagent; capture zone comprises a capture reagent for an infectious agent. (Para. 0139: different flow channels detect RSV, Flu A, Flu B) Regarding claim 25, Chang et al teach the infectious agent is a Borrelia species. (Para. 0133) Regarding claim 28, Chang et al teach each capture zone comprises a capture reagent to discriminate bacterial from viral infection. (Para. 0139: different flow channels detect RSV, Flu A, Flu B would indicate a viral infection, thus discriminate from a bacterial infection) Regarding claim 30, Chang et al teach the capture reagent is a (i) monoclonal or a polyclonal antibody, (ii) a fragment of TRAIL, CRP, IL-10, RSAD2, MX1, MX2, NGAL, PCT or (iii) a fragment of an infectious agent. (Para. 0148 polyclonal antibody) Regarding claim 31, Chang et al teach the substrate is a laminate comprising a hydrophobic material. (para. 0010: hydrophobic support layer) Claim(s) 26-27, 29 is/are rejected under 35 U.S.C. 103 as being unpatentable over Chang et al (US 2018/0229232A1) in view of Cohen et al (US 2006/0137434). Regarding claims 26-27, 29 Chang et al teach each capture zone comprises a capture reagent. Chang is silent the capture reagent is for a drug of abuse; the drug of abuse is selected from fentanyl, buprenorphine, oxycodone, and 7-aminoclonazepam; the reagents bind or interact with tumor necrosis factor-related apoptosis-inducing ligand (TRAIL), C-reactive protein (CRP), interferon-gamma-induced protein-10 (IP-10), Radical S-Adenosyl Methionine Domain Containing 2 (RSAD2), MX dynamin like GTPase I (MXI or MxA), MX dynamin like GTPase 2 (MX2 or MxB), neutrophil gelatinase-associated lipocalin (NGAL), and procalcitonin (PCT). Cohen et al teach a microfluidic device for detecting analytes including virus (influenza virus) or drugs of abuse (fentanyl) or c-reactive protein (Para. 0012). It is desirable to detect analytes that have medically relevant information, such as: viral infections, CRP to detect inflammation in your body, fentanyl to determine if patient is using illicit drugs. Simple substitution of one known element for another to obtain predictable results is held to be obvious. Therefore, it would have been obvious to one of ordinary skill in the art to substitute the capture reagents of Chang et al for the capture reagents of Cohen to detect analytes such as fentanyl or c-reactive protein to provide the above advantage of providing medically relevant information such as inflammation (CRP) and illicit drug use (fentanyl). Conclusion Any inquiry concerning this communication or earlier communications from the examiner should be directed to DENNIS MICHAEL WHITE whose telephone number is (571)270-3747. The examiner can normally be reached M-F 8:30am-5pm. Examiner interviews are available via telephone, in-person, and video conferencing using a USPTO supplied web-based collaboration tool. To schedule an interview, applicant is encouraged to use the USPTO Automated Interview Request (AIR) at http://www.uspto.gov/interviewpractice. If attempts to reach the examiner by telephone are unsuccessful, the examiner’s supervisor, Maris R. Kessel can be reached at (571) 270-7698. The fax phone number for the organization where this application or proceeding is assigned is 571-273-8300. Information regarding the status of published or unpublished applications may be obtained from Patent Center. Unpublished application information in Patent Center is available to registered users. To file and manage patent submissions in Patent Center, visit: https://patentcenter.uspto.gov. Visit https://www.uspto.gov/patents/apply/patent-center for more information about Patent Center and https://www.uspto.gov/patents/docx for information about filing in DOCX format. For additional questions, contact the Electronic Business Center (EBC) at 866-217-9197 (toll-free). If you would like assistance from a USPTO Customer Service Representative, call 800-786-9199 (IN USA OR CANADA) or 571-272-1000. /Dennis White/Primary Examiner, Art Unit 1758
Read full office action

Prosecution Timeline

Show 10 earlier events
May 22, 2025
Request for Continued Examination
May 23, 2025
Response after Non-Final Action
May 28, 2025
Non-Final Rejection mailed — §103
Aug 25, 2025
Response Filed
Sep 08, 2025
Final Rejection mailed — §103
Dec 08, 2025
Request for Continued Examination
Dec 11, 2025
Response after Non-Final Action
May 12, 2026
Non-Final Rejection mailed — §103 (current)

Precedent Cases

Applications granted by this same examiner with similar technology

Patent 12704456
METHOD FOR DETERMINING AMMONIUM
3y 5m to grant Granted Aug 11, 2026
Patent 12702975
METHODS AND DEVICES FOR LATERAL FLOW ANALYTE ASSAYS
3y 9m to grant Granted Aug 11, 2026
Patent 12702981
METHOD FOR MANUFACTURING MICROCHIP FOR BLOOD COAGULATION TEST
3y 2m to grant Granted Aug 11, 2026
Patent 12668597
HIGH-PURITY THIENOPYRIMIDINE COMPOUND AND PREPARATION METHOD THEREFOR
2y 10m to grant Granted Jun 30, 2026
Patent 12663377
REAGENT STRIP COUNTERFEIT PROTECTION
3y 6m to grant Granted Jun 23, 2026
Study what changed to get past this examiner. Based on 5 most recent grants.

Strategy Recommendation AI-generated — please review before filing

Get a prosecution strategy drawn from examiner precedents, rejection analysis, and claim mapping.
Typically takes 5-10 seconds — AI-generated, attorney review required before filing

Prosecution Projections

7-8
Expected OA Rounds
58%
Grant Probability
99%
With Interview (+48.7%)
3y 0m (~0m remaining)
Median Time to Grant
High
PTA Risk
Based on 831 resolved cases by this examiner. Grant probability derived from career allowance rate.

Sign in with your work email

Enter your email to receive a magic link. No password needed.

Personal email addresses (Gmail, Yahoo, etc.) are not accepted.

Free tier: 3 strategy analyses per month